Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
242 results:
1. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract] [Full Text] [Related]
3. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises.
Ahmad J; Ahamad J; Algahtani MS; Garg A; Shahzad N; Ahmad MZ; Imam SS
Expert Opin Drug Deliv; 2024 Feb; 21(2):229-244. PubMed ID: 38344809
[TBL] [Abstract] [Full Text] [Related]
4. The emerging role of noncoding RNAs in the PI3K/akt/mTOR signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract] [Full Text] [Related]
5. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
7. Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
Azam AS; Tsang YW; Thirlwall J; Kimani PK; Sah S; Gopalakrishnan K; Boyd C; Loughrey MB; Kelly PJ; Boyle DP; Salto-Tellez M; Clark D; Ellis IO; Ilyas M; Rakha E; Bickers A; Roberts ISD; Soares MF; Neil DAH; Takyi A; Raveendran S; Hero E; Evans H; Osman R; Fatima K; Hughes RW; McIntosh SA; Moran GW; Ortiz-Fernandez-Sordo J; Rajpoot NM; Storey B; Ahmed I; Dunn JA; Hiller L; Snead DRJ
Histopathology; 2024 Apr; 84(5):847-862. PubMed ID: 38233108
[TBL] [Abstract] [Full Text] [Related]
8. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
9. Oncological Applications of Quantum Machine Learning.
Rahimi M; Asadi F
Technol Cancer Res Treat; 2023; 22():15330338231215214. PubMed ID: 38105500
[No Abstract] [Full Text] [Related]
10. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract] [Full Text] [Related]
11. cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade cancer.
Nakai H; Nagayama H; Takahashi H; Froemming AT; Kawashima A; Bolan CW; Adamo DA; Carter RE; Fazzio RT; Tsuji S; Lomas DJ; Mynderse LA; Humphreys MR; Dora C; Takahashi N
J Am Coll Radiol; 2024 Mar; 21(3):387-397. PubMed ID: 37838189
[TBL] [Abstract] [Full Text] [Related]
12. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNAs as the critical regulators of PI3K/akt, TGF-β, and MAPK signaling pathways during breast tumor progression.
Maharati A; Moghbeli M
J Transl Med; 2023 Aug; 21(1):556. PubMed ID: 37596669
[TBL] [Abstract] [Full Text] [Related]
14. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
15. Evolutionary histories of breast cancer and related clones.
Nishimura T; Kakiuchi N; Yoshida K; Sakurai T; Kataoka TR; Kondoh E; Chigusa Y; Kawai M; Sawada M; Inoue T; Takeuchi Y; Maeda H; Baba S; Shiozawa Y; Saiki R; Nakagawa MM; Nannya Y; Ochi Y; Hirano T; Nakagawa T; Inagaki-Kawata Y; Aoki K; Hirata M; Nanki K; Matano M; Saito M; Suzuki E; Takada M; Kawashima M; Kawaguchi K; Chiba K; Shiraishi Y; Takita J; Miyano S; Mandai M; Sato T; Takeuchi K; Haga H; Toi M; Ogawa S
Nature; 2023 Aug; 620(7974):607-614. PubMed ID: 37495687
[TBL] [Abstract] [Full Text] [Related]
16. Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics.
Nayak V; Patra S; Singh KR; Ganguly B; Kumar DN; Panda D; Maurya GK; Singh J; Majhi S; Sharma R; Pandey SS; Singh RP; Kerry RG
Environ Res; 2023 Oct; 235():116573. PubMed ID: 37437865
[TBL] [Abstract] [Full Text] [Related]
17. Gene Expression Profiling of Fibroepithelial Lesions of the breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
18. UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer.
Sun Q; Li J; Dong H; Zhan J; Xiong X; Ding J; Li Y; He L; Wang J
Sci Rep; 2023 May; 13(1):8335. PubMed ID: 37221238
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/akt/mTOR signaling pathway.
Song Q; Zhang W; Shi D; Zhang Z; Zhao Q; Wang M; Huang M; Meng J; Cui W; Luo X
Cancer Med; 2023 Jun; 12(12):13538-13550. PubMed ID: 37220224
[TBL] [Abstract] [Full Text] [Related]
20. The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage breast cancer.
Ozveren A; Ridvanogullari Donger M; Motor S; Bulut G
Integr Cancer Ther; 2023; 22():15347354231165938. PubMed ID: 36987394
[TBL] [Abstract] [Full Text] [Related]
[Next]
